NCHR Testimony to FDA in Preparation for the 2017 International Cooperation on Cosmetics Regulation (ICCR) Meeting

May 25, 2017. In summary, endocrine disrupting chemicals and other harmful substances are present in many cosmetics in the United States. These substances can harm the health of adults and children, and it is essential for the FDA and the ICCR to consider the growing evidence for their harm. We urge the FDA and ICCR to establish high standards for maximum levels of endocrine disruptors and require manufacturers to clearly label their presence in products.

Read More »

NCHR Comments to EPA on Use of Lead Free Pipes

May 17, 2017. We strongly support the EPA’s efforts to establish labeling requirements and assure compliance with lead free standards for plumbing products intended for potable water systems. These regulations will help professionals, including manufacturers, distributors, and retailers, to more easily identify lead free materials and prevent the use of those that are not. Ultimately, this will reduce consumers’ exposure to lead in drinking water and help to prevent its serious, detrimental, and often irreparable health effects.

Read More »